2023
Obstetric outcome and emotional reactions to childbirth in women with dyspareunia: A cross-sectional study.
Padoa, A., Tomashev, R., Brenner, I., Golan, A., Igawa, M. S., Lurie, I., Reicher Y., Talmon A., Ginzburg, K.
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2023, 288, 7-11
Sexual trauma inquiry during psychiatric hospitalization in Israel: facilitators and barriers to implementation of trauma-informed care.
Brenner, I., Seligman, Z., Bloemhof-Bris, E., Hirschmann, S.
Harefuah, 2023, 162(8), 518–523.
Peripartum dissociation, sense of control, postpartum posttraumatic stress disorder and emotional adjustment to motherhood in adult survivors of childhood maltreatment.
Brenner, I., Ginzburg, K., Golan, A., Igawa, M. S., Lurie, I., Reicher, Y., Talmon A., Tomashev R., Padoa, A.
Archives of women’s mental health, 2023, 1-10.
Immune-related biomarkers and suicidal behaviors: A meta-analysis.
Neupane, S., Daray, F., Ballard, E., Galfalvy, H., Itzhaky, L., Segev, A., Shelef, A., Tene, O., Rizk, M., Mann, J., Zalsman, G.
European Neuropsychopharmacology, 2023, 75: 15-30.
Inflammation Markers Among Schizophrenia Patients Who Use Cannabis.
Fridman, J., Bloemhof-Bris, E., Weizman, S., Kessler, T., Porat, D., Ivry, A., Wolf, Aviva., Stryjer, R., Shelef, A.
Clinical Neuropharmacology, 2023, 10.1097
2022
Dorsomedial prefrontal rTMS for depression in borderline personality disorder: a pilot randomized crossover trial.
Feffer, K., Lee, H. H., Wu, W., Etkin, A., Demchenko, I., Cairo, T., Mazza F., Fettes P., Mansouri F., Bhui K., Daskalakis Z.J, Blumberger D.M., Giacobbe P., Downar, J.
Journal of Affective Disorders, 2022, 301, 273-280
Factors affecting the willingness of mental health staff to get vaccinated against COVID‐19.
Dahan, S., Bloemhof-Bris, E., Weizman, S., Pesah, M., Gorno, N., Abu Shah, M., Levi, G., Shelef, A.
Journal of Evaluation in Clinical Practice, 2022, 28.6: 948-957
Shared trauma during the COVID‐19 pandemic: Psychological effects on Israeli mental health nurses.
Dahan, S., Levi, G., & Segev, R.
International Journal of Mental Health Nursing. 2022 June; 31(3), 722-730.
Olanzapine intramuscular shows better efficacy than zuclopenthixol acetate intramuscular in reducing the need for restraint, but not in comparison to haloperidol intramuscular.
Sinai, O., Stryjer, R., Bloemhof-Bris, E., Weizman, S., & Shelef, A. (2022).
International Clinical Psychopharmacology. 2022; 37(1), 9-13.
Vitamin D as a Protective Factor in COVID-19 Infection in Elderly Schizophrenia and Dementia Inpatients: A Case Series.
Shelef, A., Dahan, S., Weizman, S., & Bloemhof-Bris, E.
The Israel Medical Association journal: IMAJ. 2022; 24(2), 74-77.
2021
To Tie or Not To Tie? Ethical Challenges and Dilemmas Associated With the Use of Physical Restraint in Mental Health Care.
Dahan, S., Bachner-Melman, R., Kremer, I.
Society & Welfare: Quarterly for Social Work. 2021; 2(3), 263-270 (Hebrew).
A Double-Blind, Placebo-Controlled Trial of Bupropion Add-on to Olanzapine or Risperidone in Overweight Individuals With Schizophrenia.
Weizman, S., Shelef, A., Bloemhof-Bris, E., & Stryjer, R. (2021).
Journal of clinical psychopharmacology. 2021; 41(6), 629-631.
2019
Safety, tolerability and effectiveness of a novel 20 Hz rTMS protocol targeting dorsomedial prefrontal cortex in major depression: An open-label case series.
Miron JP, Feffer K, Cash RFH, Derakhshan D, Kim JMS, Fettes P, Giacobbe P, Blumberger DM, Daskalakis ZJ, Downar J.
Brain Stimul. 2019 Sep-Oct;12(5):1319-1321.
Cognitive Impairments in Abstinent Male Residents of a Therapeutic Community for Substance-Use Disorders: A Five-Year Retrospective Study.
Shlosberg D, Amit BH, Zalsman G, Krivoy A, Mell H, Lev-Ran S, Shoval G.
Subst Use Misuse. 2019 54(4):538-548
Equine assisted therapy for patients with post traumatic stress disorder: a case series study.
Shelef, A., Brafman, D., Rosing, T., Weizman, A., Stryjer, R., & Barak, Y.
Military medicine. 2019; 184(9-10), 394-399.
2018
The association between comorbid psychiatric diagnoses and hospitalization-related factors among individuals with schizophrenia.
Kessler T, Lev-Ran S.
Compr Psychiatry. 2018 Dec 7;89:7-15. doi: 10.1016/j.comppsych.2018.12.004. [Epub ahead of print]
Getting More out of Meta-Analyses- A new approach to meta-analysis in light of unexplained heterogeneity.
Saad A, Yekutieli D, Lev-Ran S, Gross R, Guyatt G.
J Clin Epidemiol. 2018 Dec 5. pii: S0895-4356(18)30597-3. doi: 10.1016/j.jclinepi.2018.11.023. [Epub ahead of print]
DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults.
Livne O, Shmulewitz D, Lev-Ran S, Hasin DS.
Drug Alcohol Depend. 2018 Oct 16. pii: S0376-8716(18)30714-2. doi: 10.1016/j.drugalcdep.2018.09.005. [Epub ahead of print]
Medical Cannabis Use by Hodgkin Lymphoma Patients: Experience of a Single Center.
Sarid N, Zada M, Lev-Ran S, Yashphe E, Givon I, Barzilai M, Perry C, Avivi I, Wolf I.
Acta Haematol. 2018;140(4):194-202. doi: 10.1159/000493567. [Epub 2018 Oct 19].
Epidemiology of hallucinogen use in the U.S. results from the National epidemiologic survey on alcohol and related conditions III
Shalit N, Rehm J, Lev-Ran S.
Addict Behav. 2018 Sep 16;89:35-43.
Validity and clinical utility of DSM and prototype diagnosis for depressive and anxiety spectrum disorders in predicting adaptive functioning
Nakash O, Nagar M, Bentov-Gofrit D, Md E, Amiaz R, Lev-Ran S, Westen D.
Psychiatry Res. 2018 Sep 11;270:50-56.
Clinical Correlates of Cannabis Use Among Individuals With Attention Deficit Hyperactivity Disorder.
Brandt A, Rehm J, Lev-Ran S.
J Nerv Ment Dis. 2018 Sep;206(9):726-732.
Association of Cannabis With Long-Term Clinical Symptoms in Anxiety and Mood Disorders: A Systematic Review of Prospective Studies.
Mammen G, Rueda S, Roerecke M, Bonato S, Lev-Ran S, Rehm J.
J Clin Psychiatry. 2018 Jun 5;79(4)
The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: A cross-sectional study.
Feingold D, Brill S, Goor-Aryeh I, Delayahu Y, Lev-Ran S.
J Affect Disord. 2018 Aug 1;235:293-302.
Processes in psychotherapy and the Matrix: The case of Projective Identification.
Mendlovic S, Ben Yehuda A, Saad A, Sopher A, Doron A.
Psychodynamic Psychiatry. Accepted 18 April 2018.
The association between lifetime cannabis use and dysthymia across six birth decades
Livne O, Razon L, Rehm J, Hasin DS, Lev-Ran S.
J Affect Disord. 2018 Jul;234:327-334. Epub 2018 Mar 16.
The Impact of ‘Being There’: Psychiatric Staff Attitudes on the Use of Restraint
Dahan S, Levi G, Behrbalk P, Bronstein I, Hirschmann S, Lev-Ran S.
Psychiatr Q. 2018 Mar;89(1):191-199.
Patterns of cannabis use and clinical correlates among individuals with Major Depressive Disorder and Bipolar Disorder
Taub S, Feingold D, Rehm J, Lev-Ran S.
Compr Psychiatry. 2018 Jan; 80:89-96.
2017
Clinical and functional outcomes of cannabis use among individuals with anxiety disorders: A 3-year population-based longitudinal study
Feingold D, Rehm J, Factor H, Redler A, Lev-Ran S.
Depress Anxiety. 2018 Feb 27.
The MATRIX, a novel tool exploring dynamic psychotherapy: Preliminary psychometric properties.
Mendlovic S, Doron, A, Saad, A, Atzil-Slonim D, Mar’I, S, Bloch, Y, & Ben Yehuda, A.
Psychiatry Research, 2017; 258, 344–350.
Fatal Overdoses of Opioids in Israel 2005-2014
Feingold D, Goldberger N, Haklai Z, Lev-Ran S.
Eur Addict Res. 2017;23(6):276-283.
Primary Addictive Substances Used among Patients Treated in a Hospital-Based Addiction Medicine Service
Feingold D, Lev-Ran S.
Isr J Psychiatry Relat Sci. 2017;54(2):41-46.
Adverse Reactions Associated With Cannabis Consumption as Evident From Search Engine Queries
Yom-Tov E, Lev-Ran S.
JMIR Public Health Surveill. 2017 Oct 26;3(4):e77.
Fertility Treatments and Psychiatric Disorders: Ethical Considerations Regarding a Patient’s Desire to Become a Mother.
Stolovy, T., Linder, M., Zipris, P., Doron, A., Dafna, Y., & Melamed, Y. (2017).
The Israel Medical Association Journal : IMAJ, 19(1), 63–64.
Misuse of prescription opioids among chronic pain patients suffering from anxiety: A cross-sectional analysis
Feingold D, Brill S, Goor-Aryeh I, Delayahu Y, Lev-Ran S.
Gen Hosp Psychiatry. 2017 Jul;47:36-42.
Comparing triggers to visual disturbances among individuals with positive vs negative experiences of hallucinogen-persisting perception disorder (HPPD) following LSD use
Lev-Ran S, Feingold D, Goodman C, Lerner AG.
Am J Addict. 2017 Sep;26(6):568-571.
Depression and anxiety among chronic pain patients receiving prescription opioids and medical marijuana
Feingold D, Brill S, Goor-Aryeh I, Delayahu Y, Lev-Ran S.
J Affect Disord. 2017 Aug 15;218:1-7.
Cannabis use and the course and outcome of major depressive disorder: A population based longitudinal study
Feingold D, Rehm J, Lev-Ran S.
Psychiatry Res. 2017 May; 251:225-234.
Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic Pain
Feingold D, Goor-Aryeh I, Bril S, Delayahu Y, Lev-Ran S., Dahan, S., Behrbalk, P., & Greenberger, C.
Pain Med. 2017 Feb 1;18(2):294-306.
2016
Improving Adherence in Hospitalized Patients Diagnosed With Schizophrenia: An Integrative One-on-One Intervention
Dahan S, Behrbalk P, Stolovy T, Greenberger C
Archives of Psychiatric Nursing December 2016; 30, 6: 660-665
Safety and efficacy of medical cannabis oil for behavioral and psychological symptoms of dementia: an-open label, add-on, pilot study.
Shelef, A., Barak, Y., Berger, U., Paleacu, D., Tadger, S., Plopsky, I., & Baruch, Y.
Journal of Alzheimer’s disease, 51(1), 15-19.
2013
Internalization of stigma and self-esteem as it affects the capacity for intimacy among patients with schizophrenia.
Segalovich, J., Doron, A., Behrbalk, P., Kurs, R., & Romem, P.
Archives of Psychiatric Nursing. October 2013; 27(5), 231-234.